Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Education/Academic qualification
MD, Rush Medical College of Rush University - Chicago, IL
… → 2010
Research Strategic Pillar Keywords
- Specialized Health
Fingerprint
Dive into the research topics where Shikha Wadhwani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 4 Active
-
A Phase 2 Study to Evaluate the Safety and Efficacy of Atacicept in Multiple Autoimmune Glomerular Diseases (PIONEER)
Wadhwani, S. (PI)
Vera Therapeutics Inc ( Award # )
2/4/26 → 2/3/30
Project: Research project
-
A pivotal Phase 3, multicenter, randomized, double-blind, placebo-controlled study of the efficacy and safety of DMX-200 in patients with focal segmental glomerulosclerosis (FSGS) who are receiving an angiotensin II receptor blocker (ARB)
Wadhwani, S. (PI)
Dimerix Bioscience Pty Ltd ( Award # )
7/22/25 → 7/21/29
Project: Research project
-
Cardiovascular and Thromboembolic Events in Children and Adults With Glomerular Disease: Findings From the Cure GlomeruloNephropathy (CureGN) Network
GlomeruloNephropathy (CureGN) Study Consortium, Jun 2025, In: Kidney Medicine. 7, 6, 100877.Research output: Contribution to journal › Article › peer-review
Open Access -
Defining subgroups of pediatric nephrotic patients with urine proteomics
CureGN Participating Clinical Centers (PCC) through the University of North Carolina, CureGN Participating Clinical Centers (PCC) through the Pediatric Nephrology Research Consortium, CureGN Participating Clinical Centers (PCC) through Columbia University, Cure Glomerulonephropathy (CureGN) Consortium, Steering Committee Chair, Data Coordinating Center (DCC) & CureGN Participating Clinical Centers (PCC) through the University of Pennsylvania, Dec 2025, In: Scientific reports. 15, 1, 25064.Research output: Contribution to journal › Article › peer-review
Open Access -
Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis
CureGN IgA Working Group, Jul 1 2025, In: Clinical Journal of the American Society of Nephrology. 20, 7, p. 978-992 15 p.Research output: Contribution to journal › Article › peer-review
6 Link opens in a new tab Scopus citations -
The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes
Sheth, K., Kim, S., Porterfield, L., Virani, S. S., Wadhwani, S. & Vaughan, E. M., Dec 2025, In: Current Atherosclerosis Reports. 27, 1, 76.Research output: Contribution to journal › Review article › peer-review
2 Link opens in a new tab Scopus citations -
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study
Cure Glomerulonephropathy (CureGN) Study Consortium, Jan 2024, In: American Journal of Kidney Diseases. 83, 1, p. 37-46 10 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Link opens in a new tab Scopus citations